GLP-2 analog Teduglutide in active Crohn's disease and short bowel syndrome: Confirmation of anti-inflammatory role and future perspectives

Chronic intestinal failure (IF) is a condition characterized by impairment of intestinal function below the minimum necessary for growth or even survival. This often causes the necessity to start a parenteral nutrition (PN), not without further serious related complications and risk factors. IF is mainly due to Short Bowel Syndrome (SBS) and the most common cause of SBS in adults is Crohn's disease (CD), which far exceeds 60% of the prevalence [1].

Source: Digestive and Liver Disease - April 23, 2020 Category: Gastroenterology Authors: Raffaele Borghini, Roberto Caronna, Giuseppe Donato, Antonio Picarelli Tags: Commentary Source Type: research